Anti-microbial resistance: what could the future look like?

Peter Doherty Institute – Melbourne Children’s Global Health Seminar

12.30-1.30pm AEDT Monday 23 November 2020

Antimicrobial resistance (AMR) is a global health and development threat requiring urgent action. Both misuse and overuse of antimicrobials primarily drive AMR. The WHO has declared AMR to be one of the top 10 public health threats worldwide, highlighting its importance and urgency. Without effective antimicrobials, the success of modern medicine in controlling and treating infections, including during major surgery and cancer chemotherapy, is at increased risk. Much is being done to combat AMR in the region and further afield. Global health researchers have been working on innovative strategies to combat AMR, including the development of new anti-microbials and a better understanding of the microorganisms and their genes. This seminar, involving three researchers at the forefront of AMR in Global Health, give unique perspectives, new insights and their thoughts on both the current AMR situation and on what the future could look like.

“What could the future look like: Genomics for diagnosis of MDR TB and its potential for use in TB high burden countries”
Dr Sarah Dunstan, Senior Research Fellow, Peter Doherty Institute for Infection and Immunity

“Pathogen genomics and AMR – what does it tell us and how should we use it in future to deal with the threat of AMR?”
Professor Ben Howden, Director of the Microbiological Diagnostic Unit Public Health Laboratory (MDU PHL), Medical Director of the Doherty Centre for Applied Microbial Genomics and Head of the Howden Research Group, Peter Doherty Institute for Infection and Immunity

Professor Kirsty Buising, Deputy Director of the National Centre for Antimicrobial Stewardship, Peter Doherty Institute for Infection and Immunity

Professor Stephen Rogerson
, Peter Doherty Institute for Infection and Immunity

Comments are closed.